Viawealth LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.4% during the first quarter, Holdings Channel.com reports. The firm owned 9,201 shares of the healthcare conglomerate’s stock after acquiring an additional 126 shares during the period. UnitedHealth Group comprises 3.4% of Viawealth LLC’s investment portfolio, making the stock its 2nd biggest holding. Viawealth LLC’s holdings in UnitedHealth Group were worth $4,349,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Veritable L.P. grew its stake in shares of UnitedHealth Group by 2.8% during the 1st quarter. Veritable L.P. now owns 27,563 shares of the healthcare conglomerate’s stock worth $13,026,000 after purchasing an additional 748 shares during the period. Renaissance Technologies LLC lifted its position in shares of UnitedHealth Group by 169.4% during the 1st quarter. Renaissance Technologies LLC now owns 1,450,933 shares of the healthcare conglomerate’s stock valued at $685,697,000 after buying an additional 912,256 shares in the last quarter. Prospera Financial Services Inc lifted its position in shares of UnitedHealth Group by 17.3% during the 1st quarter. Prospera Financial Services Inc now owns 24,786 shares of the healthcare conglomerate’s stock valued at $11,719,000 after buying an additional 3,659 shares in the last quarter. Private Portfolio Partners LLC lifted its position in shares of UnitedHealth Group by 6.0% during the 1st quarter. Private Portfolio Partners LLC now owns 1,730 shares of the healthcare conglomerate’s stock valued at $818,000 after buying an additional 98 shares in the last quarter. Finally, Callan Family Office LLC lifted its position in shares of UnitedHealth Group by 125.5% during the 1st quarter. Callan Family Office LLC now owns 4,345 shares of the healthcare conglomerate’s stock valued at $2,053,000 after buying an additional 2,418 shares in the last quarter. Institutional investors and hedge funds own 85.69% of the company’s stock.
UnitedHealth Group Stock Down 0.8 %
Shares of NYSE:UNH opened at $480.77 on Friday. The business has a 50-day moving average price of $491.01 and a 200 day moving average price of $486.78. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $445.34 billion, a price-to-earnings ratio of 21.51, a PEG ratio of 1.40 and a beta of 0.66. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $558.10.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.92 by $0.22. The firm had revenue of $92.90 billion during the quarter, compared to the consensus estimate of $90.97 billion. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The company’s quarterly revenue was up 15.6% on a year-over-year basis. During the same period last year, the company earned $5.57 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Monday, September 11th will be paid a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.56%. The ex-dividend date is Friday, September 8th. UnitedHealth Group’s payout ratio is presently 33.65%.
Wall Street Analysts Forecast Growth
UNH has been the topic of a number of research reports. SVB Securities decreased their price objective on UnitedHealth Group from $625.00 to $560.00 in a report on Wednesday, June 14th. Morgan Stanley restated an “overweight” rating and issued a $587.00 price objective on shares of UnitedHealth Group in a report on Friday, July 14th. StockNews.com initiated coverage on UnitedHealth Group in a report on Thursday, August 17th. They issued a “buy” rating on the stock. Piper Sandler initiated coverage on UnitedHealth Group in a report on Thursday, May 25th. They issued an “overweight” rating and a $580.00 price objective on the stock. Finally, Sanford C. Bernstein upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $595.00 to $603.00 in a report on Tuesday, July 18th. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $575.65.
Read Our Latest Research Report on UNH
Insider Activity
In related news, CEO Andrew Witty sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the transaction, the chief executive officer now directly owns 78,573 shares of the company’s stock, valued at $39,772,866.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.35% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.